Archives of Gynecology and Obstetrics

, Volume 288, Issue 6, pp 1223–1229 | Cite as

Retrospective analysis on the efficacy of corticosteroid prophylaxis prior to elective caesarean section to reduce neonatal respiratory complications at term of pregnancy: review of literature

  • Simone Paganelli
  • Emanuele Soncini
  • Giancarlo Gargano
  • Francesco Capodanno
  • Cristina Vezzani
  • Giovanni Battista La Sala
Review

Abstract

Purpose

Our purpose was to conduct a systematic review of the literature to determine whether synthetic pharmaceutical glucocorticoids (betamethasone and dexamethasone) are safe as well as effective in reducing neonatal respiratory morbidity at term of pregnancy prior to elective caesarean section. The overall incidence of respiratory disorders is estimated at 2.8 %, and the main risk factors are gestational age and mode of delivery. Newborns delivered by elective caesarean section (CS after 37 weeks) are more susceptible to serious respiratory complications than babies born by vaginal delivery. Neonatal respiratory morbidity at term of pregnancy is low but not negligible. Further, it is increasing due to a drastic decline in trial of labour in those pregnant women who underwent a caesarean section in the past. Because prophylaxis is inexpensive, easy to administer, and safe, other studies should be conducted to confirm its effectiveness.

Methods

We conducted a systematic review of literature since 1965 on the discovery of action mechanisms, pharmaceutical development, proper dosage, and potential side effects of corticosteroids on the mother and offspring to extrapolate their efficacy as no clinical trial has directly demonstrated it.

Results

We extrapolated no negative effects on mother and foetus behaviour.

Conclusions

Human studies suggest that corticosteroid administration may become a proper clinical indication prior to caesarean section in the reduction of neonatal respiratory problems.

Keywords

Elective caesarean section Antenatal corticosteroids Transient tachypnea of the newborn (TTN) Respiratory distress syndrome of newborn (RDS) Dexamethasone Betamethasone 

References

  1. 1.
    Rubaltelli FF, Bonafe L, Tangucci M, Spagnolo A, Dani C (1998) Epidemiology of neonatal acute respiratory disorders. A multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery. Italian Group of Neonatal Pneumology. Biol Neonate 74:7–15PubMedCrossRefGoogle Scholar
  2. 2.
    Zanardo V, Simbi AK, Franzoi M, Solda G, Salvadori A, Trevisanuto D (2004) Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery. Acta Paediatr 93:643–647PubMedCrossRefGoogle Scholar
  3. 3.
    Farchi S, Di Lallo D, Franco F, Polo A, Lucchini R, Calzolari F, De Curtis M (2009) Neonatal respiratory morbidity and mode of delivery in a population-based study of low-risk pregnancies. Acta Obstet Gynecol Scand 88:729–732PubMedCrossRefGoogle Scholar
  4. 4.
    Gerten KA, Coonrod DV, Bay RC, Chambliss LR (2005) Cesarean delivery and respiratory distress syndrome: does labor make a difference? Am J Obstet Gynecol 193:1061–1064PubMedCrossRefGoogle Scholar
  5. 5.
    Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB (2008) Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 336:85–87PubMedCrossRefGoogle Scholar
  6. 6.
    Goldberg JD, Cohen WR, Friedman EA (1981) Cesarean section indication and the risk of respiratory distress syndrome. Obstet Gynecol 57:30–32PubMedGoogle Scholar
  7. 7.
    American Academy of Pediatrics, American College of Obstetricians and Gynecologists (2002) Guidelines for perinatal care, 5th edn. AAP/ACOG, Elk Grove Village/Washington, p 148Google Scholar
  8. 8.
    National Collaborating Centre for Women’s and Children’s Health (2004) Caesarean section. National Institute for Clinical Excellence, Clinical Guideline, LondonGoogle Scholar
  9. 9.
    Uddin SF, Simon AE (2012) Rates and success rates of trial of labor after cesarean delivery in the United States, 1990–2009. Matern Child Health JGoogle Scholar
  10. 10.
    Mathews TJ, Menacker F, MacDorman MF (2004) Centers for disease control and prevention, National center for health statistics. Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 53:1–29PubMedGoogle Scholar
  11. 11.
    Smith GC, Pell JP, Cameron AD, Dobbie R (2002) Risk of perinatal death associated with labor after previous cesarean delivery in uncomplicated term pregnancy. J Am Med Assoc 287:2684–2690CrossRefGoogle Scholar
  12. 12.
    Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O’Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG (2004) Maternal e perinatal outcomes associated with a trial of labour after prior cesarean section. N Engl J Med 351(25):2581–2589PubMedCrossRefGoogle Scholar
  13. 13.
    Peter Stutchfield, Rhiannon Whitaker, Ian Russell (2005) Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ doi:10.1136/bmj.38547.416493.06
  14. 14.
    Tanasijevic MJ, Wybenga DR, Richardson D, Greene MF, Lopez R, Winkelman JW (1994) A predictive model for fetal lung maturity employing gestational age and test results. Am J Clin Pathol 102:788–793PubMedGoogle Scholar
  15. 15.
    Baines DL, Folkesson HG, Norlin A, Bingle CD, Yuan HT, Olver RE (2000) The influence of mode of delivery, hormonal status and postnatal O2 environment on epithelial sodium channel (ENaC) expression in perinatal guinea-pig lung. J Physiol 522:147–157PubMedCrossRefGoogle Scholar
  16. 16.
    Jain L (1999) Alveolar fluid clearance in developing lungs and its role in neonatal transition. Clin Perinatol 26:585–599PubMedGoogle Scholar
  17. 17.
    Gowen CW Jr, Lawson EE, Gingras J, Boucher RC, Gatzy JT, Knowles MR (1988) Electrical potential difference and ion transport across nasal epithelium of term neonates: correlation with mode of delivery, transient tachypnea of the new born and respiratory rate. J Pediatr 113:121–127PubMedCrossRefGoogle Scholar
  18. 18.
    Venkatesh VC, Katzberg HD (1997) Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung. Am J Physiol 273:227–233Google Scholar
  19. 19.
    Jain L, Eaton DC (2006) Physiology of fetal lung fluid clearance and effect of labor. Semin Perinatol 30:34–43PubMedCrossRefGoogle Scholar
  20. 20.
    Jobe AH, Ikegami M, Padbury J, Polk DH, Korirnilli A, Gonzales LW, Ballard PL (1997) Combined effects of fetal beta agonist stimulation and glucocorticoids on lung function of preterm lambs. Biol Neonate 72:305–313PubMedCrossRefGoogle Scholar
  21. 21.
    Noone PG, Leigh MW, Sannuti A, Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR (2004) Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 169:459–467PubMedCrossRefGoogle Scholar
  22. 22.
    Ballard PL, Ballard A (1995) Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 173:254–262PubMedCrossRefGoogle Scholar
  23. 23.
    Travis R, Sayers G (1965) In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 3rd edn. Macmillan, New York, pp 1608–1648Google Scholar
  24. 24.
    Liggins GC (1969) Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 45:515–523PubMedCrossRefGoogle Scholar
  25. 25.
    Beitins IZ, Kowarski A, Shermeta DW, De Lemos RA, Migeon CJ (1970) Fetal and maternal secretion rate of cortisol in sheep: diffusion resistance of the placenta. Pediatr Res 4:129–134PubMedCrossRefGoogle Scholar
  26. 26.
    Simmer HH, Dignam WJ, Easterling WE Jr, Frankland MV, Naftolin F (1966) Neutral C-19 steroids and steroid sulfates in human pregnancy. Steroids 8:179–193PubMedCrossRefGoogle Scholar
  27. 27.
    Friedman SB, Glasgow LA, Crota LJ (1970) Plasma adrenocorticosteroid levels during experimental infections (abst.), 69th edn. The American Pediatric Society, Atlantic City, p 16Google Scholar
  28. 28.
    Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515–525PubMedGoogle Scholar
  29. 29.
    Gilstrap LC, Christensen R, Clewell WH MD, D’Alton ME, Davidson EC MD, Escobedo MB, Gjerdingen DK et al (1995) Effect of corticosteroid for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc 273:413–418CrossRefGoogle Scholar
  30. 30.
    Feldman DM, Carbone J, Belden L, Borgida AF, Herson V (2007) Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates. Am J Obstet Gynecol 197:284.e1–284.e4CrossRefGoogle Scholar
  31. 31.
    Dyer KY, Alvarez JR, Salamon CG, Apuzzio JJ, Alvarez M, Al-Khan A (2010) The influence of race on the incidence of respiratory distress syndrome after antenatal betamethasone or dexamethasone. J Reprod Med 55(3–4):124–128PubMedGoogle Scholar
  32. 32.
    Elimian A, Garry D, Figueroa R, Spitzer A, Wiencek V, Quirk JG (2007) Antenatal betamethasone compared with dexametasone (betacode trial). Obstet Gynecol 110:26–30PubMedCrossRefGoogle Scholar
  33. 33.
    Brownfoot FC, Crowther CA, Middleton P (2008) Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth (review).Cochrane Libr doi:10.1002/14651858.CD006764.pub2
  34. 34.
    Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P (1997) Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 156:178–184PubMedCrossRefGoogle Scholar
  35. 35.
    Newnham JP, Evans SF, Godfrey M, Huang W, Ikegami M, Jobe A (1999) Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Matern Fetal Med 8:81–87PubMedCrossRefGoogle Scholar
  36. 36.
    Moss TJ, Doherty DA, Nitsos I, Sloboda DM, Harding R, Newnham JP (2005) Effects into adulthood of single or repeated antenatal corticosteroids in sheep. Am J Obstet Gynecol 192:146–152PubMedCrossRefGoogle Scholar
  37. 37.
    Ogueh O, Johnson MR (2000) The metabolic effect of antenatal corticosteroid therapy. Hum Reprod Update 6:169–176PubMedCrossRefGoogle Scholar
  38. 38.
    Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J (1995) Thyrotropin-releasing hormone for prevention of neonatal respiratory disease. Lancet 345:877–882CrossRefGoogle Scholar
  39. 39.
    Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Harding JE (2005) Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365:1856–1862PubMedCrossRefGoogle Scholar
  40. 40.
    Mildenhall LFJ, Battin MR, Morton SMB, Bevan C, Kuschel CA, Harding JE (2006) Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Arch Dis Child Fetal Neonatal Ed 91:56–60CrossRefGoogle Scholar
  41. 41.
    Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, Harding JE (2005) Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 33:665CrossRefGoogle Scholar
  42. 42.
    French NP, Hagan R, Evans SF, Mullan A, Newnham JP (2004) Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behaviour. Am J Obstet Gynecol 190:588–595PubMedCrossRefGoogle Scholar
  43. 43.
    Lunshof MS, Boer K, Wolf H, Koppen S, Klijn Velderman J, Mulder EJH (2005) Short term (0–48 h) effects of maternal betamethasone administration on fetal heart rate and its variability. Pediatr Res 57:545–549PubMedCrossRefGoogle Scholar
  44. 44.
    Mulder EJH, Koenen SV, Blom I, Visser GHA (2004) The effects of antenatal betamethasone administration on fetal heart rate and behaviour depend on gestational age. Early Hum Dev 76:65–77PubMedCrossRefGoogle Scholar
  45. 45.
    Mulder EJ, de Heus R, Visser GH (2009) Antenatal corticosteroid therapy: short-term effects on fetal behaviour and haemodynamics. Semin Fetal Neonatal Med 14:151–156PubMedCrossRefGoogle Scholar
  46. 46.
    Knight DB, Liggins GC, Wealthall SR (1994) A randomized controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Am J Obstet Gynecol 171:11–16PubMedCrossRefGoogle Scholar
  47. 47.
    Vidaeff AC, Ramin SM, Gilstrap LC, Alcorn JL (2004) Characterization of corticosteroid redosing in an in vitro cell line model. Am J Obstet Gynecol 191:1403–1408PubMedCrossRefGoogle Scholar
  48. 48.
    Howie RN, Liggins CC (1982) The New Zealand study of antepartum glucocorticoid treatment. In: Farrell PM (ed) Lung development: biological and clinical perspectives, vol 2. Academic Press, New York, pp 255–265Google Scholar
  49. 49.
    Langley-Evans SC (2001) Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc Nutr Soc 60:505–513PubMedCrossRefGoogle Scholar
  50. 50.
    Dodic M, Abouantoun T, O’Conor A, Wintour EM, Moritz KM (2002) Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 40:729–734PubMedCrossRefGoogle Scholar
  51. 51.
    Drake AJ, Tang JI, Nyirenda MJ (2007) Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci (London) 113:219–232CrossRefGoogle Scholar
  52. 52.
    Nyirenda MJ, Dean S, Lyons V, Chapman KE, Seckl JR (2006) Prenatal programming of hepatocyte nuclear factor 4alpha in the rat: a key mechanism in the foetal origins of hyperglycaemia? Diabetologia 49:1412–1420PubMedCrossRefGoogle Scholar
  53. 53.
    Crowther CA, McKinlay CJ, Middleton P, Harding JE (2011) Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev doi:10.1002/14651858.CD003935.pub3

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Simone Paganelli
    • 1
  • Emanuele Soncini
    • 1
  • Giancarlo Gargano
    • 2
  • Francesco Capodanno
    • 1
  • Cristina Vezzani
    • 1
  • Giovanni Battista La Sala
    • 1
  1. 1.Department of Obstetrics and Gynecology, Arcispedale S. Maria NuovaIstituto Tecnologie Avanzate e Modelli Assistenziali in Oncologia, IRCCSReggio EmiliaItaly
  2. 2.Neonatal Intensive Care Unit (NICU), Arcispedale S. Maria NuovaIstituto Tecnologie Avanzate e Modelli Assistenziali in Oncologia, IRCCSReggio EmiliaItaly

Personalised recommendations